Tag: Ixekizumab
#VisualAbstract: Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X)
1. Ixekizumab, an IL-17 inhibitor, elicits disease response in patients with non-radiographic active axial spondyloarthritis who have failed treatment with ...
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X)
1. Ixekizumab, an IL-17 inhibitor, elicits disease response in patients with non-radiographic active axial spondyloarthritis who have failed treatment with ...
2 Minute Medicine Rewind December 9, 2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 1. Obeticholic ...
Ixekizumab may be safe and effective for chronic plaque psoriasis
1. The use of 120mg ixekizumab in a phase-III, open-label extension (OLE) trial showed improved Psoriasis Area and Severity Index ...